HCPCS code Q4171 – Interfyl 1 mg billing and Medicare coverage

Key Takeaways

Q4171 describes Interfyl, 1 mg, a non-sheet cellular and tissue-based product billed per milligram under Medicare Part B

Coverage depends on your MAC’s Local Coverage Determination – not all MACs and payers cover Interfyl, and some explicitly exclude it

Every Q4171 claim requires a separate CPT application procedure code (e.g., 97597 or 15271-15278) – the product code alone is never sufficient

Pabau’s claims management software supports structured wound care documentation that captures the measurements, treatment history, and ICD-10 diagnoses required for CTP billing

HCPCS code Q4171: Interfyl 1 mg billing and Medicare coverage guide – code definition

HCPCS code Q4171 is the billing code for Interfyl, 1 mg, a human amniotic tissue-derived cellular and tissue-based product (CTP) applied to chronic wounds that have not responded to conventional care. The code belongs to HCPCS Level II, which CMS maintains for products, supplies, and services not captured by CPT.

Unlike sheet-form skin substitutes that are cut and applied like a graft, Interfyl is classified as a non-sheet CTP, meaning it is applied in a different form, typically injectable or flowable, to fill or cover the wound bed.

Understanding this classification matters for billing. Non-sheet CTPs have their own billing rules under Medicare, separate from sheet-form products in some MAC LCD policies. Misclassifying the product form leads to claim edits or outright denial before a human reviewer ever sees the record.

Q4171 code details at a glance

Medicare coverage for Interfyl: Is Q4171 a covered benefit?

Medicare Part B covers Interfyl when billed with the appropriate application procedure code, the correct ICD-10 diagnosis, and documentation that meets the coverage criteria in the applicable MAC Local Coverage Determination.

Coverage is not automatic: each MAC publishes its own LCD for CTPs, and whether Q4171 appears as a covered product in that LCD depends on your jurisdiction. Confirming insurance eligibility verification at the payer level before the application is the single most effective step to prevent a denial that cannot be reversed after the fact.

At least one managed care plan, Superior Health Plan, lists Interfyl as a non-covered benefit. Practitioners billing under Medicaid managed care or commercial plans must verify coverage independently for each payer, not just for Medicare fee-for-service.

Which MACs cover Q4171 under their LCD?

Coverage varies by jurisdiction. The table below reflects the general LCD landscape for CTPs as of 2025, but providers must verify directly with their MAC before billing. LCD policies are updated quarterly and may change without notice.

Q4171 Medicare fee schedule: 2025 and 2026 payment rates

Medicare reimburses Q4171 per 1 mg of product actually used, not per vial or per application. The national payment rate is set annually through the CMS Medicare Physician Fee Schedule (MPFS) look-up tool, and geographic adjustment factors apply, meaning a practice in San Francisco will see a different allowed amount than one in rural Alabama.

Checking the revenue cycle management implications before applying a large quantity is worth the effort: billing 500 mg of a product reimbursed at a low per-unit rate carries real financial risk if the claim is denied.

Important: CMS does not publish a single public per-unit dollar figure that is stable across all payers and years. Always confirm the current reimbursement rate directly through the CMS MPFS look-up tool using Q4171 as the search code, and verify the geographic payment locality for your practice address.

How to bill Q4171: step-by-step billing instructions

Billing Interfyl under Medicare Part B requires more than submitting Q4171 on a claim form. The product code is paired with an application CPT code, assigned specific bill type and revenue codes depending on the setting, and supported by a diagnosis that matches the MAC’s covered ICD-10 list. A clean Q4171 claim follows this sequence:

1. Confirm MAC LCD coverage. Verify Q4171 appears on your MAC’s active covered CTP list before the treatment date. Coverage lists update quarterly. Use your MAC’s LCD document, not a third-party code database, for this step.
2. Confirm the covered ICD-10 diagnosis. The patient’s wound diagnosis must match a covered ICD-10 code in the LCD. See the diagnosis codes section below for the key codes.
3. Document prior conservative care. Most MAC LCDs require evidence that the wound received at least four weeks of standard wound care before a CTP is applied. Record wound measurements, treatment type, and response in the clinical note.
4. Calculate the quantity in milligrams. Bill Q4171 for the number of milligrams actually applied. Document the lot number and expiration date of the product used.
5. Select the correct application CPT code. Q4171 is a product code only. A separate CPT application procedure code is always required on the same claim.
6. Assign bill type and revenue codes. Code assignment depends on whether the service is billed in a physician office (non-facility) or outpatient hospital setting.
7. Submit with supporting documentation. Attach or make available the wound care note, product documentation, and prior treatment history to support medical necessity.

Practices that structure their workflow around these steps see significantly fewer Q4171 claim edits. Claims management software can surface missing documentation fields before a claim reaches the clearinghouse, reducing the administrative burden of a post-submission denial.

CPT application codes to pair with Q4171

Q4171 must always be submitted alongside a CPT procedure code for the wound application itself. The CPT selection depends on wound size and the type of debridement or preparation performed. The table below covers the most commonly paired codes, per CMS guidance on CTPs and procedure code pairing:

Bill type codes and revenue codes for Q4171

Reduce Q4171 claim denials with Pabau

Pabau’s claims management and digital documentation tools help wound care practices capture every required field before a CTP claim is submitted. See how structured clinical workflows protect your reimbursement.

Book a demo

ICD-10 diagnosis codes covered with Q4171

Every Q4171 claim must include an ICD-10-CM diagnosis code that matches the MAC’s covered diagnosis list. Selecting a diagnosis code that is on the LCD’s covered list but does not accurately reflect the documented wound is a coding error, not a billing shortcut. Selecting a diagnosis that accurately reflects the wound but is not on the covered list results in denial. The goal is accurate documentation that happens to align with coverage, which is achieved by treating only the wounds the LCD covers.

The following categories represent the wound types typically covered under MAC LCDs for CTPs, per CMS Medicare Coverage Database Article 56696. Always verify against your MAC’s current LCD text, as covered diagnosis lists are updated periodically. Understanding medical billing compliance requirements is essential before submitting CTP claims.

Documentation requirements for Q4171 claims

Documentation failure is the leading cause of Q4171 claim denial. The CMS Medicare Coverage Database and MAC LCDs specify what must appear in the medical record, and reviewers look for each element individually. A note that describes the wound treatment without recording the prior conservative care history, or one that logs the product applied without the lot number, will not support the claim on audit. Building digital intake forms around these requirements reduces the documentation burden at the point of care.

Required documentation for Q4171 billing includes:

• Confirmed wound diagnosis matching a covered ICD-10-CM code in the applicable MAC LCD
• Wound measurements at each visit: length, width, and depth in centimeters, plus wound bed description
• Prior conservative wound care history of at least four weeks (the specific duration may vary by MAC LCD – verify against your jurisdiction’s text)
• Physician order for the CTP application specifying the product and quantity
• Product documentation: manufacturer name, product name (Interfyl), lot number, expiration date, and quantity used in milligrams
• Treatment plan documenting the rationale for CTP use and the expected outcome
• Response to prior treatment: documented evidence that standard care failed to achieve wound closure or meaningful healing progress

Practices that use superbill documentation workflows linked to structured wound care templates are less likely to miss a required field. Keeping medical billing workflows integrated with clinical documentation from the first visit reduces the rework involved in pre-submission audits.

Does Q4171 require prior authorization?

Medicare fee-for-service generally does not require prior authorization for CTP applications including Q4171, but that applies only to traditional Medicare. Medicaid managed care, Medicare Advantage plans, and commercial payers often have different requirements, and some require prior authorization or a step-therapy process before approving advanced wound care products. Confirming claim denial management procedures before the application date is more effective than appealing after a denial.

• Traditional Medicare (FFS): Prior authorization generally not required for CTPs, but LCD coverage criteria still apply
• Medicare Advantage plans: Plans set their own prior authorization rules; verify with the specific plan before application
• Medicaid managed care: Requirements vary by state and managed care organization; some plans exclude CTPs entirely
• Commercial payers: Most require prior authorization for advanced wound care products; obtain approval before treatment
• Superior Health Plan: Interfyl is listed as a non-covered benefit – do not bill Q4171 to this plan

Related HCPCS codes: Q4171 in the context of skin substitute CTPs

Q4171 is one of dozens of HCPCS codes in the Q4100-Q4280 range for CTPs. When Interfyl is unavailable or when a different product is clinically indicated, coders select the code for the specific product applied. Billing the wrong product code, even for a similar amniotic product, is a coding error. The AAPC HCPCS code lookup is a useful reference for locating the correct descriptor for each product in the Q-code series.

Note that Q4171 is billed per milligram while most sheet-form CTPs are billed per square centimeter. Confusing these units on a claim is a common error that generates claim edits across the Q-code series. Practices that handle multiple CTP products benefit from compliance management tools that flag unit mismatches before submission.

Streamlining Q4171 documentation in practice

The gap between a Q4171 coding reference and a payable claim is documentation. Wound care practitioners who work from a coding guide but capture clinical notes in a disconnected system end up with accurate codes attached to incomplete records. The denials that result are not coding errors. They are documentation failures that happen to look like coding errors on the remittance advice.

Pabau’s structured patient records support wound care documentation workflows that capture the fields MAC LCDs require: wound measurements at each visit, product lot numbers, prior treatment history, and ICD-10 diagnosis codes linked to the treatment record.

When those fields are built into the clinical workflow rather than added retrospectively to support a claim, documentation compliance becomes a byproduct of normal care delivery rather than a separate administrative task.

Practices using HIPAA-compliant documentation systems that link clinical notes to billing outputs also reduce the time spent preparing records for MAC audits. Clean claim submission rates improve when the documentation feeding the billing system is structured from the first visit.

Conclusion

Q4171 is a straightforward code to look up and a complex one to bill cleanly. MAC-level LCD variability, per-milligram unit calculation, mandatory CPT pairing, and multi-element documentation requirements combine to make Interfyl claims more denial-prone than most HCPCS codes.

Getting the claim right the first time requires verifying MAC coverage before the application date, documenting every required element at the point of care, and pairing the product code with the correct application CPT for the wound location and size.

Pabau’s claims management and documentation tools help wound care practices build these steps into the clinical workflow rather than chasing documentation after the fact.

To see how claims management software supports CTP billing compliance, book a demo with the Pabau team.

Continue your research

List Item #1

List Item #2

New List Item

Frequently Asked Questions